Literature DB >> 28841386

Androgen Deprivation Therapy and Dementia: New Opportunities and Challenges in the Big-Data Era.

Kevin T Nead1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28841386     DOI： 10.1200/JCO.2017.74.8806

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Neurocognitive impairment associated with traditional and novel androgen receptor signaling inhibitors ± androgen deprivation therapy: a pharmacovigilance study.

Authors:  Logan G Briggs; Stephen Reese; Peter Herzog; David-Dan Nguyen; Muhieddine Labban; Khalid Alkhatib; Quoc-Dien Trinh; Alicia K Morgans
Journal:  Prostate Cancer Prostatic Dis       Date:  2022-04-18       Impact factor: 5.554

Review 2.  Androgen Deprivation Therapy and Cognitive Function in Prostate Cancer.

Authors:  Jonathan Kluger; Alicia Roy; Herta H Chao
Journal:  Curr Oncol Rep       Date:  2020-02-11       Impact factor: 5.075

3.  Correlation of Androgen Deprivation Therapy with Cognitive Dysfunction in Patients with Prostate Cancer: A Nationwide Population-Based Study Using the National Health Insurance Service Database.

Authors:  Bum Sik Tae; Byung Jo Jeon; Seung Hun Shin; Hoon Choi; Jae Hyun Bae; Jae Young Park
Journal:  Cancer Res Treat       Date:  2018-07-18       Impact factor: 4.679

Review 4.  Biomarkers to Evaluate Androgen Deprivation Therapy for Prostate Cancer and Risk of Alzheimer's Disease and Neurodegeneration: Old Drugs, New Concerns.

Authors:  Vérane Achard; Kelly Ceyzériat; Benjamin B Tournier; Giovanni B Frisoni; Valentina Garibotto; Thomas Zilli
Journal:  Front Oncol       Date:  2021-12-15       Impact factor: 6.244
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.